Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Warning Letters
Manufacturing
ImmunityBio gets FDA snub on cancer drug, shares crash
ImmunityBio was hit with a complete response letter by the FDA for its bladder cancer prospect, sending its stock into a steep slide.
Joseph Keenan
May 11, 2023 9:40am
Sun Pharma pauses US drug exports from India plant
Apr 27, 2023 9:35am
FDA cites complaint-plagued Cipla facility in scathing report
Mar 7, 2023 9:35am
Amneal plant slapped by FDA for sanitary issues and more
Feb 28, 2023 9:40am
Piramal gets FDA resolution in KY; begins production in MI
Feb 16, 2023 10:32am
Troubled Torrent plant gets FDA 'official action' letter
Jan 24, 2023 9:00am
